Nagao, K., Matsuyama, H., Nozawa, M., Hara, I., Nishioka, T., Komura, T., . . . Uemura, H. (2016). Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propensity scoring approach. Asian J Urol.
Citação norma ChicagoNagao, Kazuhiro, et al. "Zoledronic Acid Combined With Androgen-deprivation Therapy May Prolong Time to Castration-resistant Prostate Cancer in Hormone-naïve Metastatic Prostate Cancer Patients – A Propensity Scoring Approach." Asian J Urol 2016.
MLA CitationNagao, Kazuhiro, et al. "Zoledronic Acid Combined With Androgen-deprivation Therapy May Prolong Time to Castration-resistant Prostate Cancer in Hormone-naïve Metastatic Prostate Cancer Patients – A Propensity Scoring Approach." Asian J Urol 2016.